Skip to main content
. 2023 Aug 24;6:870. doi: 10.1038/s42003-023-05243-w

Fig. 5. The performance of GCAP on Oxycodone-analog drugs.

Fig. 5

a The differences of attention scores of the MGA module for each atom in the molecular graph between five Oxycodone-analogous drugs interacting with CS. The darker the color is, the higher the attention value at the corresponding position is. b The differences of representations calculated by the MGA module between five Oxycodone-analogous drugs interacting with CS. c, d These show the predictive performance of GCAP for predicting the seriousness of adverse reactions to five Oxycodone-analogous drugs. Due to the fact that the clinical outcomes of some Oxycodone-analogous drugs related ADRs do not have all seven seriousness classes in the benchmark dataset, the AUC and AUPR of some Oxycodone-analogous drugs in the figure are zeros on the determination task of the class of serious clinical outcomes caused by drug–ADR interactions.